RCM
GILD icon

Raleigh Capital Management’s Gilead Sciences GILD Stock Holding History

Raleigh Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Sell
2,017
-9
-0.4% -$1.19K 0.08% 185
2026
Q1 		$282K Sell
2,026
-6,614
-77% -$926K 0.1% 175
2025
Q4 		$1.06M Sell
8,640
-1,520
-15% -$185K 0.38% 73
2025
Q3 		$1.13M Sell
10,160
-2,660
-21% -$302K 0.43% 70
2025
Q2 		$1.42M Sell
12,820
-6,315
-33% -$672K 0.6% 54
2025
Q1 		$2.14M Sell
19,135
-11,048
-37% -$1.14M 0.97% 20
2024
Q4 		$2.79M Sell
30,183
-3,014
-9% -$271K 1.07% 13
2024
Q3 		$2.78M Buy
33,197
+7,801
+31% +$595K 1.07% 15
2024
Q2 		$1.74M Buy
25,396
+1,248
+5% +$83.3K 0.74% 33
2024
Q1 		$1.77M Buy
24,148
+4,576
+23% +$352K 0.76% 38
2023
Q4 		$1.59M Sell
19,572
-396
-2% -$30.8K 0.74% 40
2023
Q3 		$1.5M Buy
19,968
+2,148
+12% +$165K 0.76% 43
2023
Q2 		$1.37M Sell
17,820
-9,528
-35% -$760K 0.69% 49
2023
Q1 		$2.27M Sell
27,348
-19,149
-41% -$1.59M 1.12% 20
2022
Q4 		$3.99M Sell
46,497
-3,924
-8% -$311K 2.08% 3
2022
Q3 		$3.11M Buy
50,421
+10,140
+25% +$639K 1.82% 4
2022
Q2 		$2.49M Buy
40,281
+13,013
+48% +$806K 1.42% 12
2022
Q1 		$1.62M Buy
27,268
+27,194
+36,749% +$1.74M 0.88% 28
2021
Q4 		$5K Buy
+74
New +$5.1K 0.01% 234

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Raleigh Capital Management's GILD Position: Q2 2026 in Review

Raleigh Capital Management reduced its Gilead Sciences (GILD) stake by 0.44% in Q2 2026, selling an estimated $1.19K and leaving 2,017 shares worth $255K. The position accounts for 0.08% of the portfolio, ranked #185.

Raleigh Capital Management first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.99M in Q4 2022. 642 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Raleigh Capital Management held 2,017 shares of Gilead Sciences worth $255K as of Q2 2026.
  • Raleigh Capital Management sold 9 Gilead Sciences shares in Q2 2026, an estimated $1.19K.
  • Gilead Sciences made up 0.08% of Raleigh Capital Management's portfolio in Q2 2026, its #185 holding.
  • Raleigh Capital Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Raleigh Capital Management's Gilead Sciences position peaked at $3.99M in Q4 2022.
  • 642 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.